Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan-Mar;19(1):1-55.
doi: 10.4103/atm.atm_248_23. Epub 2023 Dec 15.

The Saudi initiative for asthma - 2024 update: Guidelines for the diagnosis and management of asthma in adults and children

Mohamed Saad Al-Moamary  1 , Sami A Alhaider  2 , Riyad Allehebi  3 , Majdy M Idrees  4 , Mohammed O Zeitouni  5 , Mohammed O Al Ghobain  1 , Abdullah F Alanazi  1 , Adel S Al-Harbi  6 , Abdullah A Yousef  7 , Hassan S Alorainy  8 , Mohamed S Al-Hajjaj  9
Affiliations

The Saudi initiative for asthma - 2024 update: Guidelines for the diagnosis and management of asthma in adults and children

Mohamed Saad Al-Moamary et al. Ann Thorac Med. 2024 Jan-Mar.

Abstract

The Saudi Initiative for Asthma 2024 (SINA-2024) is the sixth version of asthma guidelines for the diagnosis and management of asthma for adults and children that was developed by the SINA group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up-to-date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA Panel approach is mainly based on the assessment of symptom control and risk for both adults and children. The approach to asthma management is aligned for age groups: adults, adolescents, children aged 5-12 years, and children aged <5 years. SINA guidelines have focused more on personalized approaches reflecting a better understanding of disease heterogeneity with the integration of recommendations related to biologic agents, evidence-based updates on treatment, and the role of immunotherapy in management. The medication appendix has also been updated with the addition of recent evidence, new indications for existing medication, and new medications. The guidelines are constructed based on the available evidence, local literature, and the current situation at national and regional levels. There is also an emphasis on patient-doctor partnership in the management that also includes a self-management plan.

Keywords: Asthma; Saudi Arabia; asthma control test; guidelines.

PubMed Disclaimer

Conflict of interest statement

The SINA is fully sponsored by the Saudi Thoracic Society.

Figures

Box 2.1
Box 2.1
Immunopathology of asthma
Box 6.1
Box 6.1
The SINA approach for asthma treatment dinitiation based on ACT score for adults an adolescents
Box 6.2
Box 6.2
The SINA pproach for asthma treatment adjustment and maintenance for adults and adolescents
Box 6.3
Box 6.3
SINA 2024 simplified the approach for asthma treatment for adults and adolescents
Box 6.4
Box 6.4
Algorithm for selection of appropriate biologics for severe asthma
Box 7.3
Box 7.3
Initial management of acute asthma for adults and adolescents
Box 7.4
Box 7.4
Adjustment of acute asthma treatment for adults and adolescent
Box 9.10
Box 9.10
The childhood asthma control test
Box 9.11
Box 9.11
The SINA Approach for Asthma Treatment Initiation for children aged 5 to 12 years
Box 9.12
Box 9.12
The SINA Approach for Outpatient management of Asthma for childern aged 5 to 12 years
Box 9.13
Box 9.13
The Test for Respiratory and Asthma Control in Kids (TRACK)
Box 9.14
Box 9.14
The SINA Approach for Asthma Treatment Initiation for children aged less than 5 years
Box 9.15
Box 9.15
The Saudi Initiative for Asthma approach for outpatient management of asthma for children aged <5 years
Box 10.3
Box 10.3
Assessment and treatment of acute asthma in children
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023;33:7. - PMC - PubMed
    1. Venkatesan P. 2023 GINA report for asthma. Lancet Respir Med. 2023;11:589. - PubMed
    1. Al Ghobain MO, Algazlan SS, Oreibi TM. Asthma prevalence among adults in Saudi Arabia. Saudi Med J. 2018;39:179–84. - PMC - PubMed
    1. Mohamed Hussain S, Ayesha Farhana S, Mohammed Alnasser S. Time trends and regional variation in prevalence of asthma and associated factors in Saudi Arabia: A systematic review and meta-analysis. Biomed Res Int. 2018;2018:1–9. - PMC - PubMed
    1. Alatawi A, Alanazi M. Barriers of asthma care among asthmatic children in Saudi Arabia: Maternal perspectives. Open J Pediatr. 2020;10:302.

LinkOut - more resources